- Home
- AVPT vs RCKT Comparison
AVPT vs RCKT Comparison
Compare AVPT & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVPT
- RCKT
- Stock Information
- Founded
- AVPT 2001
- RCKT 1999
- Country
- AVPT United States
- RCKT United States
- Employees
- AVPT N/A
- RCKT N/A
- Industry
- AVPT Computer Software: Prepackaged Software
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- AVPT Technology
- RCKT Health Care
- Exchange
- AVPT Nasdaq
- RCKT Nasdaq
- Market Cap
- AVPT 2.3B
- RCKT 1.9B
- IPO Year
- AVPT N/A
- RCKT N/A
- Fundamental
- Price
- AVPT $12.47
- RCKT $17.13
- Analyst Decision
- AVPT Buy
- RCKT Strong Buy
- Analyst Count
- AVPT 4
- RCKT 9
- Target Price
- AVPT $12.75
- RCKT $53.22
- AVG Volume (30 Days)
- AVPT 510.6K
- RCKT 731.3K
- Earning Date
- AVPT 11-07-2024
- RCKT 11-04-2024
- Dividend Yield
- AVPT N/A
- RCKT N/A
- EPS Growth
- AVPT N/A
- RCKT N/A
- EPS
- AVPT N/A
- RCKT N/A
- Revenue
- AVPT $299,879,000.00
- RCKT N/A
- Revenue This Year
- AVPT $21.04
- RCKT N/A
- Revenue Next Year
- AVPT $17.26
- RCKT $300.20
- P/E Ratio
- AVPT N/A
- RCKT N/A
- Revenue Growth
- AVPT 19.57
- RCKT N/A
- 52 Week Low
- AVPT $7.08
- RCKT $15.98
- 52 Week High
- AVPT $12.67
- RCKT $32.53
- Technical
- Relative Strength Index (RSI)
- AVPT 61.51
- RCKT 46.41
- Support Level
- AVPT $11.92
- RCKT $17.05
- Resistance Level
- AVPT $12.18
- RCKT $17.75
- Average True Range (ATR)
- AVPT 0.30
- RCKT 0.72
- MACD
- AVPT -0.00
- RCKT 0.06
- Stochastic Oscillator
- AVPT 79.62
- RCKT 40.23
About AVPT AvePoint Inc.
AvePoint Inc provides customizable solutions to optimize SaaS operations, enable secure collaboration, and accelerate digital transformation across technologies and industries. Its Confidence Platform delivers a comprehensive set of cloud-based solutions enabling IT operations, development operations, and cybersecurity professionals to monitor and secure the digital workplace using SaaS tools.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis.